Clorox has long carried the reputation of a dependable household products player, yet Q1 2027 results just reminded investors that dependable does not mean dull. The stock closed at US$93.80 on November 4, up 4.3% on the day, as the market reacted to a cleaner earnings print than many feared.
What really grabbed attention was profits. Net income for the quarter landed at US$170 million and basic earnings per share came in at about US$1.40. For a consumer staples company built on bleach, trash bags and wipes, that level of earnings power in a tricky cost backdrop helped drive the gap between cautious expectations and a relief rally in the share price.
Love the cleaner Clorox earnings print but concerned about concentration risk in one consumer staples stock? See how it stacks up against peers with stronger balance sheets and fundamentals in our list of solid balance sheet and fundamentals stocks (24 results).
Q1 2027 Earnings Summary
- Revenue (Q1 2027 vs Q1 2026): US$1,905 million vs. US$1,429 million (up about 33.3%)
- Net Income (Excl. Extra Items, Q1 2027 vs Q1 2026): US$170 million vs. US$80 million (up about 112.5%)
- Basic EPS (Q1 2027 vs Q1 2026): US$1.40 vs. US$0.65 (up about 114.2%)
- Trailing Twelve Month Net Income (Excl. Extra Items, Q1 2027 vs Q1 2026): US$677 million vs. US$791 million (down about 14.4%)
Tired of scrolling through walls of earnings tables and footnotes to piece together Clorox's story? Get a full visual breakdown of the business, with a clear view of its recent earnings power and valuation in our company report for Clorox..
Evaluating Clorox’s ProCare And ERP Bull Case
The bullish story hangs on operational tools quietly lifting earnings quality rather than headline growth.
"Bullish analysts expect Clorox to compound earnings over time as the ERP program moves from rollout to optimization and begins to deliver the margin and productivity benefits that were only partially reflected in earlier expectations."
Q1 shows some of that thesis getting real support. Revenue and EPS both outpaced last year and guidance, while management described ERP as shifting into a value creation phase and highlighted faster than expected GOJO integration with line of sight to about US$50 million of cost synergies. Flat to slightly positive underlying organic sales guidance suggests the uplift is coming from execution and efficiency, not a hot category.
Not everyone reads the same price the same way. → See the higher figure this Narrative lands on, and how it gets there.
Clorox Bear Case: Cash And ERP Fears Partly Intact
The skeptical view argues that Clorox’s transformation hinges on systems and cash improvements that may not arrive quickly enough to relieve margin strain.
"The main thing that has to go right is that Clorox turns its ERP rollout, GOJO integration and health and hygiene platform into lasting productivity and cash flow improvements that offset elevated input costs, ERP-related inefficiencies and ongoing pressure in weaker businesses like Fresh Step Litter."
Q1 earnings and EPS came in strong, yet FY27 guidance now points to EPS at the low end as inflation rises to about US$240 million and organic sales excluding ERP effects remain only flat to slightly positive. Free cash flow and dividend coverage concerns are not resolved in this print.
Hunt For Mispriced Earnings Power
Clorox just showed how cleaner execution and expectations can collide in a single quarter. The real opportunity is finding stocks that could be undervalued before the broader market closes that gap.
- Company 1 - 38% below our estimate - uses new capacity expansion and a high-horsepower engine platform to pursue larger power contracts for data-heavy customers.
- Company 2 - 49% below our estimate - turns heavy AI infrastructure spending into ad tools and business messaging products for automated campaign targeting and optimization.
- Company 3 - 28% below our estimate - positions custom silicon, connectivity and security products where rising data traffic must be processed, moved and protected across large-scale digital infrastructure.
That is three of the list. See every one of the 34 undervalued companies on it →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com